May 24, 2022 / 05:15PM GMT
Colin Bristow -
Good afternoon, everyone, and thank you for attending the UBS Global Healthcare Conference. I'm Colin Bristow, one of the biotech analysts here. It is my pleasure to have with us today, Royalty Pharma. From Royalty, we have Marshall Urist, EVP and Co-Head of Research and Investments; and Chris Hite, EVP and Vice Chairman. Thank you for joining us today.
Christopher Hite - Royalty Pharma plc - Executive VP & Vice Chairman
Thank you.
Marshall Urist - Royalty Pharma plc - Executive VP and Head of Research & Investments
Thanks, Colin.
Colin Bristow -
(Operator Instructions) There we go. So I know you have some opening remarks. So I'll let you take it away, and then we'll dig into some of the questions.
Christopher Hite - Royalty Pharma plc - Executive VP & Vice Chairman
Okay. Great. I think Marshall and I will do a quick spin through some slides and then obviously open up to Q&A. So -- but thank you very much for
Royalty Pharma PLC at UBS Global Healthcare Conference Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers